“We have used Portfolio Navigator to better understand a potential inlicensing opportunities for our R&D pipeline. In one example, we had engaged in many discussions about the pros and cons of a licensing opportunity for a product in the early-to-mid stage of clinical development, but struggled with a number of issues that prevented us from reaching a yes/no decision for almost two years. With Portfolio Navigator, we were able to model this uncertainty by explicitly capturing the intellectual property (IP) risk in terms of the impact on dollar value and then modeling various components of the risk. When we saw the outputs in Portfolio Navigator, we came to the realization that even with these IP risks, the project was valuable to us at the time, and that the decision-makers could accept the risks because the range of uncertainty was now transparent. Portfolio Navigator allowed us to master the impact of uncertainty with a rigor that we did not have before.”